Haoxi Health Technology Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing covers the month of June 2026 for Haoxi Health Technology Limited, a foreign private issuer headquartered in Beijing, China. The report discloses an "Other Event" consisting of the issuance of a Notice of Extraordinary General Meeting of Shareholders and a Proxy Card.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document solely announces the convening of an Extraordinary General Meeting.
Guidance, Outlook, and Risks
The filing contains no management guidance, outlook, or discussion of risks and contingencies. It notes that the Notice of the Extraordinary General Meeting (Exhibit 99.1) contains important information regarding the Company and the meeting, which shareholders are urged to read carefully. The filing also states that the Notice is not subject to review by the SEC.
Key Facts for Investor Verification
- Verify the specific agenda items and proposals to be voted on in the attached Notice of Extraordinary General Meeting (Exhibit 99.1).
- Confirm the record date and deadline for proxy submission as detailed in the Notice.
- Review the Company's website (http://www.haoximedia.com/) for the full text of the Notice and Proxy Card.
- Note that the filing is signed by Zhen Fan, Chief Executive Officer and Chairman, on June 24, 2026.